Another step towards game-changing drug development through synthetic biology.
In case you weren’t sure if we are living in the future, Organovo is here to remind you: The bioprinting company announced today that its 3D printed liver tissue is now commercially available, and pharmaceutical laboratories can begin using it to test if their early-stage drugs are toxic.
The tissue is made from three types of cells found in the human liver. Liver cells need to be arranged in a very precise pattern or they don’t work. That means 3D tissue can give clearer results than the 2D collections of cells that labs currently use because the cells interact and mimic a full liver more convincingly. Organovo said it also makes the drug discovery process faster and, as a result, cheaper.
Organovo prints its liver tissue with a machine that isn’t that far removed from the inkjet printers that can be found on a desktop. Needle-like nozzles lay down the cells in…
View original post 86 more words